Delivery Order SPE2DB22D2211-SPE2DB23FPEX7
- Not listed
- This federal contract award, valued at $1,970.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, and is a firm fixed-price delivery order with a completion date of May 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,262.88 firm fixed-price delivery order is for the supply of 4563691739 - MUPIROCIN 2% CREAM 15GM, with a completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.49 firm fixed-price delivery order is for the supply of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,405.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, with a period of performance through July 25, 2024. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
- This federal contract award is for the delivery of MUPIROCIN 2% CREAM 15GM to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a firm fixed price of $1,066.68 and a completion date of May 3, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as Amerisourcebergen. The $1,893.13 firm fixed price delivery order is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product. The contract has a completion date of January 18, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has provided a range of pharmaceutical...
- This federal contract award, with ID SPE2DB25D7067|SPE2DB25FSURK, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.58 firm-fixed-price delivery order is for the supply of 4567514778 - MUPIROCIN 2% OINTMENT 22GM, with a completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $3,128.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4568236646 - MUPIROCIN 2% CREAM 15GM. The contract is a Firm Fixed Price Delivery Order with a performance period through May 14, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,494.32 firm fixed-price delivery order is for the supply of Mupirocin 2% Cream in 15 gram tubes. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FPEX7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.54 Firm Fixed Price Delivery Order is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product. The contract has a completion date of September 20, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - a $999,999,999 IDC with the DLA Troop Support Medical for a broad range of pharmaceutical and medical supplies, and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs serve as primary vehicles for Amerisourcebergen to provide essential pharmaceutical and medical commodities to support military healthcare programs, veterans' healthcare, and other federal medical institutions. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/19/23 |